Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
1
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
 3
was merely based on the previous reports without any further investigation or information on pharmacological activities or phytochemical composition (Thirumurugan et al., 2018).
TABLE 1.1 Plant-Based Secondary Metabolites as Antimicrobial Agents
Secondary Metabolites Source Activity References
Alkaloids
Affinin Capsaicin Lupanine
Anthraquinone
Hypericin
Glycosides
Glucoiberin
Glucoiberverine
Lignans
Dibenzocyclooctadiene Styraxjaponoside C
Phenols
Catechol Eugenol Gallic acid
Pyrogallol Resveratrol
Tannins
Ellagic acid
Terpenes
p-Cymene Thymus sp.
Limonene
Terpenoids
Carvacol
Thymol
Capsicum annuum Capsicum annuum Lupinus angustifolius
Hypericum perforatum
Lobularia libyca
Lobularia libyca
Schissandra chinensis Styrax japonica
Phoenix dactylifera Syzygium aromaticum Terminalia chebula,
Leea indica Emblica officinalis Veratrum grandiflorum
Terminalia chebula
Citrus aurantium
Origanum vulgare
Thymus vulgaris
Antibacterial De and Goswami (2021) Antibacterial, Antiparasitic Antibacterial Romeo et al. (2018)
Antibacterial Khorshidian
Antifungal, Antibacterial Chandra
Antifungal, Antibacterial Negro
Antibacterial Antifungal Ferdes (2018)
Antibacterial Ferdes (2018) Antibacterial Ferdes (2018) Antiparasitic, Antibacterial
Antibacterial Chew et al. (2022) Antibacterial, Antiviral,
Antifungal
Antibacterial Savic
Antiviral, Antiparasitic, Antibacterial
Antibacterial, Antiviral, Antibiofilm
Antibacterial, Antifungal Memar
Antibacterial, Antifungal Sepahvand
⏎
Menezes
Ferdes (2018)
et al. (2022)
Chandra et al. (2017)
Choińska
Abedini et al. (2021)
et al. (2019)
Balahbib et al. (2021)
Gupta et al. (2021)
et al. (2017);
Ferdes (2018)
et al. (2022)
et al. (2018)
et al. (2017);
et al. (2021)
et al. (2021)
At the beginning of the 19th century, the actual drug discovery from the plant origin
was initiated, when a German scientist isolated painkillers and a sleep-inducing agent
TABLE 1.2 Plant-Based Secondary Metabolites as Anticancer Agents
Secondary Metabolites Source Chemical Nature Effective against the Type
Apigenin Artemisinin Artesunate Berberine Betulin Camptothecin Cryptotanshinone Curcumin Docetaxel Emodin Gingerol Irinotecan Kaempferol Noscapine Paclitaxel Panaxadiol Paradol Podophyllotoxin Quercetin
Resveratrol Roscovitine Salvicine Shogaol Sulforaphane
Matricaria chamomilla Artemisia annua Artemisia annua Berberis vulgaris Betula sp. Camptotheca acuminate Salvia prionitis Curcuma longa Taxus sp. Aloe vera Zingiber officinale Camptotheca acuminate Vitis vinifera slyvestris Papaver somniferum Taxus sp. Panax ginseng Zingiber officinale Podophyllum sp. Curcuma domestica, Cuscuta
reflexa, Daucus carota Vitis vinifera slyvestris Raphanus sativus Salvia prionitis Zingiber officinale Brassica oleraceae
Flavone Breast, lung, liver Choudhury Sesquiterpene lactone Lung Slezáková and Ruda-Kucerova (2017) Sesquiterpene lactone Breast, lung, colon Liu Alkaloid Breast, colon Xu et al. (2019) Triterpene Breast, lung, colon Król et al. (2015) Alkaloid Lung, pediatric FDA (2020) Quinoid diterpene Breast, lung Wu Diferuloyl methane Pancreas, breast Pastorelli et al. (2018) Terpenoid Lung, ovarian and breast Seca and Pinto (2018) Anthraquinone Lung, breast, liver Pecere Hydroxy ketone Colorectal Danwilai et al. (2017) Alkaloid Ovarian, lung, colorectal Wahid (2016) Flavonoid Ovarian, pancreatic Kashyap Pthalideisoquinoline Leukemia, lung, breast Tripathi et al. (2014) Alkaloid Lung, ovarian, breast Moraes et al. (2017) Triterpenoid saponin Colon Li et al. (2009) Phenolic ketones Breast, colon Al-Abbasi et al. (2016) Lignan Lymphomas, testicular Moraes et al. (2017) Flavonol Gastric Tang et al. (2020); Khursheed et al.
Polyphenolic phytoalexin Colorectal, breast Malaguarnera (2019); Fan Purine Lung, breast FDA (2020) Quinone Breast, lung Benzenoids Breast, colon Zhu et al. (2013) Isothiocyanate Prostate, breast Chartoumpekis et al. (2020)
⏎
of Cancer
4 
References
et al. (2013)
et al. (2011)
et al. (2016)
et al., (2000); Xing et al. (2015)
et al. (2017)
(2020)
et al. (2020)
Deng et al. (2011)
 5
from opium and named morphium (morphine). He came up with a detailed paper based on the isolation, structure, and pharmacological properties of opium. The discovery of opium prompted the investigation of more medicinal plants. Consequently, in the following decades of the 19th century, various natural products with bioactivity, mainly the “alkaloid” class of chemicals, which includes atropine, caffeine, capsaicin, cocaine, codeine, colchicine, nicotine, and quinine were isolated from natural resources. For the
rst time pharmaceutical industries were established by pharmacists who were trained in the isolation of these compounds. H.E. Merck was the rst established pharmaceutical
company that initiated the isolation of morphine and other alkaloids in 1826. Among the
synthesis of natural compounds, salicylic acid was the rst compound to be synthesized in
the laboratory in 1853 (Chinou, 2008; Thirumurugan et al., 2018). After the discovery of the drug from microbial resources, pure compounds took over the use of extracts and partly
puried extracts. Despite the advancement in chemistry and related disciplines during the
last few decades, therapeutic agents originating from natural products are still in high demand.
Phytochemicals from the plant origin are usually classied as primary and secondary
metabolites.

It is normal for all plants to produce constituents as a result of their usual metabolic activities. Primary metabolites are classified as those chemicals, which are essential for the survival of plant cells. These include sugars, amino acids, fats, and nucleotides, which are almost present in every type of cell in respective proportions. They have been identi­fied in all species, families, and genera of plants since they are the key components in a plant’s survival. They help in the production of polymers, considered to be an important necessity of a plant. The biochemistry involved in these simple chemicals is distinguished from the generation of other complex molecules formed as a result of divergent pathways (Itokawa et al., 2008; Anulika et al., 2016).

Secondary metabolites constitute a class of compounds, which are produced and decomposed and are necessary for the whole plant. They do not have any particular role in the primary metabolism of the plant including growth, photosynthesis, and reproduction. They play a critical role in chemical adaptation triggered due to different environmental stresses, and chemical defense against microorganisms, insects, and other plants. The role of secondary metabolites as pollinator attractants is another important characteristic that plays a vital role in plant reproduction. These metabolites are used commercially as nutraceuticals, fragrances, vegetable oils, spices, and medicinal drugs. Precisely secondary metabolites are known as biologically active agents, which present higher quality but a lower quantity in comparison with primary metabolites (Chinou, 2008; Thirumurugan et al., 2018).
6 
The secondary metabolites’ synthesis occurs in distinct types of plant cells, unlike primary metabolites. As their synthesis involves various developmental stages, it makes their isolation and extraction more effortful. This class of phytochemicals extensively varies from one plant to another. Each type of plant family, genus, or species synthesizes its characteristic chemical class or a mixture of them (Chinou, 2008). These metabolites
have been classied into three major categories as terpenoids, phenolics, and nitrogen-
containing compounds.
T erpenoids are a chemical class of compounds made up of carbon and hydrogen entirely .
Analytically, terpenoids are produced by a ve-carbon building unit structure which leads
to the production of compounds having C5, C10, C15, C20, and up to C40 structural
skeletons. Terpenoids are dened as a broad class of natural products, synthesized by a
biosynthetic pathway based on mevalonate as a parent, comprising subgroups such as
isoprenoids and steroids. Terpenoids are further classied based on the building units such
as monoterpenoids, sesquiterpenoids, diterpenoids, triterpenoids, carotenoids, and so on. The occurrence of terpenoids is common in higher plants, algae, lichens, liverworts, and mosses. Among the bioactive class of natural products, diterpenoids presented a wider scope of biological activities (Itokawa et al., 2008; Anulika et al., 2016).
The second major chemical class of secondary metabolites includes phenolics. Phenolics are aromatic compounds with the replacement of the hydroxyl group. The parent molecule of these compounds is phenol but most of them are complex molecules and the complexity is determined by the number of carbon atoms present in the basic skeleton. The derived classes of phenol contain at least one or more chains such as salicylic acid, caffeic acids, hydroxycinnamic acid, and so on. Phenolic compounds from the plant origin are produced via two main biosynthetic pathways; either through shikimic acid, also known as benzoic acid derivatives, lignans, coumarins, and so on, or through acetate, resulting in polyketides, which develop by cyclization to products such as xanthones and quinines. The important classes of phenolics isolated from plants are benzoquinones, phenolic acids, hydroxycin-
namic acids, xanthones, avonoids, lignans, and tannins. These phenolic compounds
possess potential medicinal value and are widely used as allelopathic substances, fungicidal agents, antioxidants, and antimicrobial agents (Anulika et al., 2016).
Nitrogen-containing secondary metabolites are considered the most diversied class of
chemical compounds. These compounds may occasionally contain sulfur in their chemical
structure. Amino acids are divided into two main groups specically from plant origin such
as protein and nonprotein amino acids. Plant protein amino acids are important in carrying out distinct extracellular and intracellular functions of the plant. They play a critical role in guarding against possible predators and are usually stored in the seeds of plants. They are essential in the human diet but some of them are toxic to humans as well. These compounds have been utilized in drug development such as l-Dopa which is a therapeutic agent for Parkinson’s disease. Among others, alkaloids are a group of nitrogen-containing chemical compounds that exhibit potential pharmacological properties. The structure of
alkaloids is highly diversied from being very simple, complex and extremely complex structures. They are classied based on the amino acids, a precursor of their synthesis.
They can be found mostly in the Solanaceae, Papaveraceae, Fabaceae, Rubiaceae, and
Berberidaceae families. They could be classied into ve major groups which include
 7
pyridine and piperidine, tropine, quinoline, isoquinoline, and indole alkaloids (Chinou, 2008; Anulika et al., 2016).

1.2.2 MICROBIAL NATURAL PRODUCTS

Microbes-based natural products are moieties that are produced by microorganisms such as bacteria, fungi, and actinomycetes. These are commonly used in medicine, agriculture, and industry, and have a wide range of applications because of their diversified structure. The majority of chemotherapeutic agents used in modern medicine are isolated from microor­ganisms. Studies on microbial biosynthetic diversity revealed huge reservoirs of natural products, many of which are yet to be discovered (Milshteyn et al., 2014; Seal et al., 2018).
Drug classes based on microbes-derived natural products include antimicrobials, antifungals, immunosuppressants, antitumor agents, and enzymes. Antibiotics and related bioactive products derived from microorganisms have been opted for by human beings for billions of years. These bioactive molecules are produced by microorganisms as a defense mechanism and are utilized to suppress other microbial competitors, and they have been extensively studied and utilized for their potential therapeutic uses (Seal et al., 2018).
Numerous secondary metabolites isolated from microbes possess signicant antimicrobial,
antitumor, and other biological potentials. These secondary metabolites, along with their sources and biosynthetic origin are summarized in Tables 1.3–1.5.
Penicillin, one of the rst antibiotics produced by the fungus Penicillium was discovered in 1928. The rise in the contemporary period of microbial-based therapeutics, mainly antibiotics started in the 1940s and lasted for about 30 years. During this period, several microbial-based medications, such as tetracycline, erythromycin, and streptomycin were discovered and many of them are still in use today. However, the period was rather brief due to the development of antibiotic resistance. Among pathogenic-resistant microbes, the ESKAPE pathogen group, which includes Acinetobacter baumannii, Enterobacter sp., Enterococcus faecium, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus are most common and concerned bacteria (Challinor and Bode,
2015). The second important class of fungal β-lactam antibiotics, cephalosporins were
discovered in 1943, about 15 years after the discovery of penicillin (Karwehl and Stadler,
2016). The fungal-based natural products including cephalosporins and penicillin were found to be effective against Gram-positive bacteria, whereas partially synthetic derivatives were found to be effective against resilient Gram-negative bacteria as well (Karwehl and Stadler, 2016). Altogether, numerous antibiotics have originated from the genus Bacillus such as lantibiotics, gramicidin, and bacteriocin. Another group of bacteria, myxobacteria, soil-dwelling bacteria, acquires the largest genomes of all bacteria and is known to possess an array of novel secondary metabolites. It is reported that more than 500 natural products
originated from terrestrial as well as marine Myxobacteria, including the rst derived
antibiotic, ambruticin in 1977 (Challinor and Bode, 2015).
Several antibiotics have been derived from Gram-positive bacteria, such as members of actinomycetales which produced more than 500 antibiotics. Out of 500, 90% of the antibiotics are produced solely by the genus Streptomyces. The discovery of streptomycin
TABLE 1.3 Microbes-Based Secondary Metabolites as Antimicrobial Agents
Secondary Metabolites Source Biosynthetic Origin References
Actinomycin Adriamycin Albomycin Amphomycin Amphotericin B Avermectin Bleomycin Candicidin Capreomycin Cephalosporin Chlorobiocin Clavulanic acid (Augmentin) Daptomycin Daunorubicin Epothilone Erythromycin Fusidic acid Geldanamycin Gentamicin Josamycin Kirromycin Milbemycin Mitomycin C
Monensin Natamycin (pimaricin)
Streptomyces anulantus Streptomyces peucetius Streptomyces sp. Streptomyces canus Streptomyces nodosus Streptomyces avermitilis Streptomyces verticilus Streptomyces sp. Saccharothrix mutabilis Cephalosporium acremonium Streptomyces roseochromogenes Streptomyces clavuligerus Nonomuraea sp. Streptomyces peucetics Sorangium cellulosum Saccharopolyspora erythraea Fusidium coccineum Streptomyces hygroscopicus Micromonospora purpurea Streptomyces narbonensis Streptomyces collinus Streptomyces hygroscopic Streptomyces lavendulae Streptomyces
caespitosus Streptomyces cinnamonesis Streptomyces sp.
⏎
NRPS Charousová PKS II Ikeda et al. (2014); Marinescu (2021) Peptidyl-nucleoside Lin NRPS Sharma et al. (2014) PKS I Svahn et al. (2015) PKS I Abokwidir and Fleischer (2015) NRPS-PKS I Baltz (2011); Chopra and Dhingra (2021) PKS I Králová NRPS Dijkstra et al. (2018) NRPS Hobson et al. (2021) Aminocoumarine Katz and Baltz (2016) Other Huttner NRPS Sader et al. (2011) PKS II Katz and Baltz (2016); Chopra and Dhingra (2021) NRPS-PKS I Kimura PKS I Challis (2014) Terpine PKS I Lamoth et al. (2015) Aminoglycoside Bibb et al. (1978); Katz and Baltz (2016) PKS I Dhawan et al. (2012) NRPS-PKS I McHugh et al. (2022) PKS I Niimi et al. (2022) Quinone Katz and Baltz (2016); Pacios et al. (2021)
PKS I Mimouni et al. (2014) PKS I Santonicola et al. (2017)
et al. (2019)
et al. (2020)
et al. (2020)
Hobson et al. (2021)
8 
et al. (2019)
et al. (2021)
TABLE 1.3
Secondary Metabolites Source Biosynthetic Origin References
Neomycin Oxytetracycline Penicillin Phosphomycin Pleuromutalin Polymyxin (D) Rebeccamycin Rifamycin Ristocetin Salinomycin Spiramycin Streptomycin Streptothricin Teicoplanin Tetracenomycin Tetracycline Thiostrepton Tylosin Undecylprodigiosin Viomycin Virginiamycin
Notes: NRPS: Nonribosomal peptide synthetase; PKS: Polyketide synthase; RiPP: Ribosomally-synthesized and post-translationally-modified peptide.
(Continued)
Streptomyces fradiae Streptomyces rimosus Penicillium crysogenum Streptomyces wedmorensis Clitopilusscyphoides Paenibacillus polymyxa Lechevalieria aerocolonegenes Amycolatopsis mediterranei Amycolatopsis lurida Streptomyces albus Streptomyces ambofaciens Streptomyces griseus Streptomyces sp. Actinoplanes teichomyceticus Streptomyces glaucescens Streptomyces rimous Streptomyces azureus Streptomyces fradiae Streptomyces coelicolor Streptomyces sp. Streptomyces virginiae
Aminoglycoside PKS II Payne et al. (2021) NRPS Bachmann et al. (2014) Phosphone Sherry and Howden (2018) Diterpene Wang NRPS Tietz and Mitchell (2016) Alkaloid Desouky PKS I Baltz (2014); Hiramine et al. (2021) NRPS Katz and Baltz (2016) PKS I Antoszczak and Huczyński (2019) PKS I Qaisar Aminoglycoside Breton and Reynolds (2013) Aminoglycoside Dowgiallo NRPS Koppen et al. (2019) PKS II Sedeek et al. (2022) PKS II Hobson et al. (2021) RiPP Kim et al. (2019) PKS I Cazer et al. (2020) Other Ramesh et al. (2021) NRPS Akbergenov et al. (2011) NRPS, NRPS-PKS I Edrington et al. (2014)
Baltz (2007); Blanchard et al. (2016)
et al. (2022)
et al. (2022)
et al. (2017)
et al. (2022)
 9
10 
and streptothricin in the 1940s led to the discovery of several other candidates through extensive screening. Nonetheless, it is predicted that only a small part of antibiotics have been discovered from Streptomyces and there are many to discover yet (Challinor and Bode, 2015).
TABLE 1.4 Microbes-Based Secondary Metabolites as Antitumor Agents
Secondary Metabolites Source Biosynthetic Origin References
Actinomycin Adriamycin
Daunorubicin Epothilone Geldanamycin Mitomycin C Paclitaxel Several endophytic fungi Isoprenoid Bibb et al. (1978);
Rebeccamycin Staurosporine
Streptozotocin
Tetracycline
Notes: NRPS: Nonribosomal peptide synthetase; PKS: Polyketide synthase.
TABLE 1.5
Secondary Metabolites
Acarbose
Cyclosporin A Lipstatinc (Xenical) Lovastatin
Rapamycin
Notes: NRPS: Nonribosomal peptide synthetase; PKS: Polyketide synthase.
Microbes-Based Secondary Metabolites as Miscellaneous Agents
Streptomyces anulantus Streptomyces peucetius
Streptomyces peucetics Sorangium cellulosum Streptomyces hygroscopicus Streptomyces lavendulae
Lechevalieria aerocolonegenes Streptomyces staurosporeus Streptomyces achromogenes Streptomyces rimous
Source Biosynthetic
Origin
Actinoplanes sp.
Tolypocladium inflatum Streptomyces toxitricini Aspergillus terrus
Streptomyces hygroscopicus
Glycoside Antidiabetic Chopra and Dhingra
NRPS Immunomodulator Fatty acyl-lactone Antiobesity Bérdy (2012) PKS Cardiovascular Baltz (2006); Chopra
NRPS-PKS I Immunomodulator
NRPS PKS II Ikeda et al. (2014);
PKS II Hendlin NRPS-PKS I Kimura et al. (2020) PKS I Lamoth et al. (2015) Quinone Pacios et al. (2021)
Alkaloid Weissman (2015) Alkaloid Baltz (2006) Glucosamine nitrosourea PKS II Hobson et al. (2021)
Pharmacological Uses
⏎
Charousová et al. (2019)
Marinescu (2021)
et al. (1969)
Atanasov et al. (2015)
Bentley et al. (2002)
⏎
References
(2021); Singh (2022)
Heeb et al. (2011)
and Dhingra (2021) Bhanot et al. (2011);
Tasneen et al. (2012)
et al.
In addition to their medicinal properties, microbial-based natural products are also utilized in the food and beverage industries. For example, the bacterium Lactobacillus is used in the production of yogurt and other fermented dairy products, while the fungus, Saccharomyces cerevisiae is used in the production of bread and beer. Overall, microbial-
based natural products have signicant potential for a variety of applications, and ongoing research is continuing to identify new uses and potential therapeutic benets.
 11

1.3 IMPORTANCE OF ANALYTICAL TECHNIQUES

1.3.1 A GLANCE AT EXTRACTION TECHNIQUES

The quantity of an active ingredient or desired secondary metabolites is always fairly low in natural resources. The extensive lab use and time-consuming extraction and isolation protocols have been the main obstacle in the practice of natural products as drug candidates. Extraction is an initial step in the separation of desired natural products from raw materials or natural resources. Some of the common extraction techniques include solvent extraction, distillation methods, pressing and sublimation methods (Zhang et al., 2018). The most applicable method is solvent extraction. Below given are a few key factors which contribute to various phases involved in the isolation of natural products.
1. Penetration of solvent into the solid matrix
2. Dissolution of solute
3. Diffusion of solute out of the solid matrix
4. Collection of isolated solute
Components that enhance the solubility and diffusion of the solute in the above phases will promote the extraction process. Among other factors, the selection of solvent, raw materials particle size, the solvent-to-solid ratio, duration, and temperature govern the
efciency of the extraction process (Brusotti et al., 2014; Zhang et al., 2018).
The isolation of a single molecular moiety is quite difcult from the complex mixture, comprising fats, oils, avonoids, alkaloids, tannins, and glycosides. Both conventional and
modern techniques are available to isolate secondary metabolites from natural resources. Conventional techniques such as maceration, percolation, distillation, and reux extrac­tion are associated with multiple disadvantages, which include the consumption of excess volume of solvents and longer time of extraction. On the contrary, modern technologies
including supercritical uid extraction, pressurized liquid extraction, electrical energy
extraction, microwave-assisted extraction, and ultrasound-assisted extraction have been
practiced to rule out difculties in extraction mainly the requirement of a larger volume of
solvents and long duration of extraction. With the advent of modern extraction techniques, complications associated with conventional methods could be sorted out with enhanced selectivity (Zhang et al., 2018; Najmi et al., 2022).
Chromatographic procedures are dened as a group of techniques utilized for the isola­tion of compounds from a mixture by continuous distribution between two phases, one of which is the mobile phase and the other is the stationary phase. Several chromatographic techniques employed for the isolation of desired compounds include paper chromatography , thin layer chromatography , gas chromatography , high-performance liquid chromatography , and liquid chromatography-mass spectrometry (Najmi et al., 2022).
There are certain other factors that inuence the concentration level and type of
secondary metabolites. These factors mainly cover plant age, altitude of the site, type of soil, collection time, species, and so on. The chemical constitution of plants primarily relies on the type of species as well as environmental factors (Visht and Chaturvedi, 2012).
12 

1.3.2 MICROBIAL CULTURING TECHNIQUES

Another isolation methodology is culture-based techniques. In the culture-based technique, bacteria are separated from their environment, cultured in monoculture fermentation broths, followed by organic extraction, and then tested for bioactivity. Different factors such as broth composition, pH, and temperature associated with the culture technique are modified to increase the range of bacteria to be grown in the laboratory. As the efficiency of easily attainable bacteria declines, scientists are focused on the advancement of culture techniques and the employment of the activation of a silent gene cluster for previously uncultured bacteria (Milshteyn et al., 2014). There are a few techniques, which have been attempted to improve the culture of bacteria in a laboratory through:
1. Activation of cryptic metabolism
2. Exploitation of genetic/genomic sequence
3. Metagenomics, involving activation of silent pathways via host and cluster engi­neering or activation of the cryptic cluster in native hosts
4. Modification of host
It is important to take note that uncultured bacteria are primarily not “unculturable” bacteria. That particular group of bacteria is not able to be cultured under the man-made native habitat in the laboratory. Although multiple attempts have been made to culture those bacteria, unfortunately, they are not able to grow well in native man-made habitats. The in-vitro culture of bacteria encloses the bacteria to grow within a partially permeable membrane, which allows the penetration of nutrients and growth factors but not cells. Another method to promote the culture techniques includes the cultivation of a supporting membrane suspended on a soil slurry. These improvements in the culture techniques
resulted in the identication of novel molecules, which could be utilized against specic pathogens such as lassomycin, a ribosomal cyclic peptide with signicant efcacy against
Mycobacterium tuberculosis (Milshteyn et al., 2014).

1.3.3 OUTLOOK AND PERSPECTIVES IN NANOPARTICLES

The applications of natural products in drug development are limited despite of high therapeutic values. There are certain restrictions associated with the application of natural products in the development of a drug, which mainly includes bioavailability , solubility , and target specificity . Bioavailability refers to the degree to which a molecule, such as a nutrient or a drug, is absorbed and is available for the body to be utilized. The nature of a molecule or drug plays a decisive act in the degree and rate of absorption when administered via any pathway. Bioavailability can be influenced by other factors such as the presence of other compounds that may enhance or inhibit the degree of absorption and the delivery systems.
Numerous approaches can be implemented to augment the bioavailability of natural products including the use of novel delivery systems such as liposomes, transfersomes, ethosomes, niosomes, phytosomes, nanoparticles, nanoemulsions, micelles, and many more (Ansari et al., 2012). These nanodrug delivery systems (NDDS) possess an extraordinary